相关实验视频
Updated: Jun 4, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
84.7K
缺氧通过抑制MHC-I表达和抗原呈现来促进瘤免疫逃避
Hala Estephan1, Arun Tailor2, Robert Parker2
1Department of Oncology, The University of Oxford, Oxford, OX3 7DQ, UK.
The EMBO journal
|January 3, 2025
概括
瘤中的缺氧降低了MHC I类的调节,并降低了T细胞的识别. 抑制自或线粒体代谢可以恢复抗原呈现并改善抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 缺氧,低氧,在固体瘤中普遍存在.
- 缺氧与对癌症疗法的耐药性有关,包括免疫疗法.
- 低毒性瘤可以逃避T细胞的识别和杀死.
研究的目的:
- 阐明缺氧促进瘤免疫逃避的分子机制.
- 研究缺氧对MHC I类表达和抗原呈现的影响.
- 探索针对缺氧诱导的免疫抑制的治疗策略.
主要方法:
- 对缺氧瘤的分析,以评估MHC I类表达和免疫组.
- 调查自和未折叠蛋白质反应 (UPR) 在缺氧诱导的免疫逃避中的作用.
- 使用基于免疫的液体染色体质谱法 (LC-MS).
- 在实验性瘤中使用呼吸道复合物-I抑制剂.
主要成果:
- 缺氧降低了MHC I类表达的调节,并以依赖氧气的方式减少了抗原 (免疫体) 的呈现.
- 缺氧通过UPR的PERK臂激活自,导致抗原呈现减少.
- 在低氧条件下抑制自会增强抗原呈现.
- 使用I复合体抑制剂减少线粒体代谢会增加瘤氧化,MHC I级水平和免疫群.
结论:
- 缺氧通过降低MHC I类和通过自活性激活抗原呈现来驱动瘤免疫逃避.
- 针对缺氧诱导的自或线粒体新陈代谢可能代表增强抗瘤免疫力的新疗法策略.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
797
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K